Outcome of therapy-related myeloid neoplasms treated with azacitidine
Journal of Hematology & Oncology, 08/02/2012
Fianchi L et al. – The study reports efficacy of azacitidine (AZA) in the largest series of therapy–related MN patients treated with 5–AZA. The data show that blasts and karyotype maintain their important prognostic role in t–MN also in the azacitidine era.